(PharmaNewsWire.Com, February 27, 2018 ) Birth controls are been used since ancient times but the safe and effective methods are introduce and available from 20th century. Contraceptive drugs are used to prevent the unwanted pregnancy by blocking the normal process of ovulations or by altering the process which support the fertilization of egg. Global Contraceptive Drugs Market is driven by increasing need of population controls and increasing prevalence of sexually transmitted diseases.
The Global Contraceptive Drugs Market is expected to reach US$ 22.15 billion by the end of the 2023 with a CAGR of 6.5%.
Necessity of avoiding the unwanted pregnancy especially in the teenage women and increasing awareness among peoples also contributed in the growth of the market. Contraceptive pills is the third most widely used contraceptive method. Government initiatives for increasing education and promoting used of contraceptive for avoiding unwanted birth have also played an important role in the growth of market. While the side effects of the treatment and strict governmental rules in many countries may hamper the growth of the market. Beside this cultural and religious opposition in developing countries is also responsible for hindering the market.
Segmentation:
Global Contraceptive Drugs Market is segmented on two category type and end user. On the basis of type they are oral contraceptive, injectable and other. Oral contraceptives are further sub segmented into combined oral contraceptive pills and progestogen-only pills. On the basis of end user they are segmented as hospitals, clinics and others.
Key Players for global contraceptive drugs market:
Merck & Co., Inc (US), Pfizer Inc (US), Teva Pharmaceutical Industries Ltd. (Israel), Bayer AG (Germany), Allergan plc. (Ireland), Janssen Global Services llc. (US), Mankind Pharma Ltd. (India), Piramal Enterprises Ltd (India), Reckitt Benckiser Plc (UK), Church & Dwight (US), The Female Health Company (US), Mayer Laboratories (US), Cooper Surgical (US).
Global Contraceptive Drugs Market is dominated by America. Increasing awareness among the people and high incidence rates of abortion has driven America Contraceptive Drugs Market. Europe command the second largest market which is followed by Asia Pacific. Increasing need of population control in Asia Pacific is the major driving factor for the growth of the market. Beside this increasing governmental initiatives to increase the reproductive education also contributed for the growth of the market.
Table of Contents:
1 Introduction 2 Research Methodology 3 Market Dynamics 4 Market Factor Analysis 5 Global Contraceptive Drugs Market, By Type 6 Global Contraceptive Drugs Market, By End User 7 Global Contraceptive Drugs Market, By Region 8 Competitive Landscape 9 Company Profile 10 Conclusion 11 Appendix
Company profiling with detailed strategies, financials, and recent development activities Market Strategic Business Influence Data Market Research Future recommendations in key business segments based on the market estimations Market share analysis of the top industry players Market forecasts for a minimum of 5 years of all the mentioned segments, Trends and the regional markets With SWOT Analysis About Market Research Future:
At Market Research Future (MRFR), we enable our customers to unravel the complexity of various industries through our Cooked Research Report (CRR), Half-Cooked Research Reports (HCRR), Raw Research Reports (3R), Continuous-Feed Research (CFR), and Market Research & Consulting Services.
We are pleased to offer you this exciting, new, and entirely free professional resource. Visit our Free Biotechnology & Pharmaceuticals resource center today to browse our selection of 600+ complimentary Biotechnology & Pharmaceuticals magazines, white papers, webinars, podcasts, and more. Get popular titles including:
